A DNA Tetrahedron–Delivered miR-17-5p mimic exerts dual anti-inflammatory and Anti-Pseudomonas aeruginosa effects in cystic fibrosis
Yunfei Ye, YinHeRichard Sun, Hawraa Shahrour, Irene Oglesby, Yiran Zheng, Catherine M Greene · 2026
Read A DNA Tetrahedron–Delivered miR-17-5p mimic exerts dual anti-inflammatory and Anti-Pseudomonas aeruginosa effects in cystic fibrosis by Yunfei Ye, YinHeRichard Sun, Hawraa Shahrour, Irene Oglesby, Yiran Zheng, Catherine M Greene (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/PMC13451911.txt.
Description
Ye and colleagues built a tiny DNA carrier in 2026 to treat cystic fibrosis lung disease. Cystic fibrosis is an inherited disease with thick mucus, long lung inflammation, and lasting infection by Pseudomonas germs. Their carrier is a DNA tetrahedron, a four-sided frame, holding a copy of a small RNA called miR-17-5p. This RNA lowers interleukin-8, a signal that pulls immune cells into the lung.
The carrier entered human airway cells in lab tests and cut interleukin-8 output after germ exposure. It also slowed Pseudomonas growth and weakened biofilms, which are sticky germ layers that resist drugs. Treated germs became far more sensitive to the antibiotic cefotaxime. Gene tests showed the RNA copy lowered genes the germs use for growth and for building biofilms, including pilL and pslA.
Catalog record
| CREATOR | Yunfei Ye, YinHeRichard Sun, Hawraa Shahrour, Irene Oglesby, Yiran Zheng, Catherine M Greene |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 63 KB |
| LICENSE | https://creativecommons.org/licenses/by/4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |